Bonita Libman is a Rheumatology/Immunology physician affiliated with University of Vermont Medical Center. OpenAlex indexes 15 publications with 252 citations (h-index 8).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
111 Colchester Ave
East Pavilion Level 5 Rheumatology
Burlington, VT 054011473
Telephone
802-847-4574Registry record last updated 4 Oct 2013.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
49.7%Folate Analog Metabolic Inhibitor19.5%Methotrexate100%Part D≥99 patientsTNF inhibitor10.9%Enbrel Sureclick46%Humira(Cf) Pen42%Cimzia (2 Pack)12%Part D<11 patients+ 9 more classes in this area
Metabolism & gastrointestinal
16.2%Corticosteroid10.7%Prednisone100%Part D≥72 patientsProton pump inhibitor2.1%Rabeprazole Sodium62%Omeprazole38%Part D<11 patients+ 2 more classes in this area
Antiparasitic
14.9%Antimalarial14.9%Hydroxychloroquine Sulfate100%Part D≥71 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Survey on the continued impact of COVID‐19 on immunocompromised patients in rheumatology
Musculoskeletal Care
2023 - Efficacy of Combination Therapy with the JAK Inhibitor Baricitinib in the Treatment of COVID-19
SN Comprehensive Clinical Medicine
2022
Similar KOLs
Other experts from the same institution or the same specialty.
Martin Lewinter, MD
University of Vermont Medical Center
Seth Harlow, MD
University of Vermont Medical Center
Bruce Tranmer, MD
University of Vermont Medical Center
Daniel Lustgarten, MD, PhD
University of Vermont Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”